Title A study of the efficacy of the bradykinin antagonist, NPC 567, in rhinovirus infections in human volunteers.
Author Higgins, P G; Barrow, G I; Tyrrell, D A
Journal Antiviral Res Publication Year/Month 1990-Dec
PMID 1965113 PMCID PMC7134172
Affiliation 1.MRC Common Cold Unit, Harvard Hospital, Salisbury, Wiltshire, U.K.

In a double-blind placebo controlled trial intranasal NPC 567, a bradykinin antagonist, failed to alleviate the symptoms of experimental rhinovirus colds. Indeed, there was evidence that the drug enhanced the symptoms although no irritant effect was detected on the uninfected nasal mucosa.

  • Copyright © 2023
    National Institute of Pathogen Biology, CAMS & PUMC, Bejing, China
    All rights reserved.